Melatonin sensitizes human breast cancer cells to ionizing radiation by downregulating proteins involved in double-strand DNA break repair

DNA Repair by Homologous Recombination, But Not by Nonhomologous End Joining, Is Elevated in Breast Cancer Cells

(2015) Zhiyong Mao et al.   NEOPLASIA

DNA-PK: A dynamic enzyme in a versatile DSB repair pathway

(2014) Anthony J. Davis et al.   DNA REPAIR

Melatonin down-regulates MDM2 gene expression and enhances p53 acetylation in MCF-7 cells

(2014) Sara Proietti et al.   JOURNAL OF PINEAL RESEARCH

Regulation of L1 expression and retrotransposition by melatonin and its receptor: implications for cancer risk associated with light exposure at night

(2014) Dawn deHaro et al.   NUCLEIC ACIDS RESEARCH

Fulvestrant radiosensitizes human estrogen receptor-positive breast cancer cells

(2013) Jing Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Optimal combination of radiotherapy and endocrine drugs in breast cancer treatment

(2013) Z.J. Zeng et al.   Cancer Radiotherapie

Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved

(2013) Per Eystein Lønning et al.   ENDOCRINE-RELATED CANCER

The modulatory effect of melatonin on genotoxicity of irinotecan in healthy human lymphocytes and cancer cells

(2012) Renata Kontek et al.   DRUG AND CHEMICAL TOXICOLOGY

Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin

(2011) M. D. Mediavilla et al.   CURRENT MEDICINAL CHEMISTRY

Melatonin interferes in the desmoplastic reaction in breast cancer by regulating cytokine production

(2011) Virginia Alvarez-García et al.   JOURNAL OF PINEAL RESEARCH

In Vivo Inhibition of the Estrogen Sulfatase Enzyme and Growth of DMBA-Induced Mammary Tumors by Melatonin

(2010) A. Gonzalez et al.   CURRENT CANCER DRUG TARGETS

Melatonin suppresses tumor angiogenesis by inhibiting HIF-1α stabilization under hypoxia

(2010) Shi-Young Park et al.   JOURNAL OF PINEAL RESEARCH

Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells

(2009) C Martínez-Campa et al.   BRITISH JOURNAL OF CANCER

The DNA-damage response in human biology and disease

(2009) Stephen P. Jackson et al.   NATURE

Genetic Evidence That the Non-Homologous End-Joining Repair Pathway Is Involved in LINE Retrotransposition

(2009) Jun Suzuki et al.   PLoS Genetics

Mechanism of Eukaryotic Homologous Recombination

(2008) Joseph San Filippo et al.   Annual Review of Biochemistry

Melatonin as a Selective Estrogen Enzyme Modulator

(2008) S. Cos et al.   CURRENT CANCER DRUG TARGETS

ERCC1/XPF limits L1 retrotransposition

(2008) Stephen L. Gasior et al.   DNA REPAIR

Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells

(2008) A. Gonzalez et al.   JOURNAL OF PINEAL RESEARCH

Concurrent hormone and radiation therapy in patients with breast cancer: what is the rationale?

(2008) Cyrus Chargari et al.   LANCET ONCOLOGY

Use of the Rad51 promoter for targeted anti-cancer therapy

(2008) C. M. Hine et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA